• 1. An all-solid-state asymmetric device based on a polyaniline hydrogel for a high energy flexible supercapacitor?
  Hamid Heydari,Mohammad B. Gholivand New J. Chem., 2017,41, 237-244
• 2. An amide probe as a selective Al3+ and Fe3+ sensor inside the HeLa and a549 cell lines: Pictet–Spengler reaction for the rapid detection of tryptophan amino acid?
  Bidyut Kumar Kundu,Rinky Singh,Ritudhwaj Tiwari,Debasis Nayak New J. Chem., 2019,43, 4867-4877
• 3. An artificial photosynthesis system comprising a covalent triazine framework as an electron relay facilitator for photochemical carbon dioxide reduction?
  Siquan Zhang,Shengyao Wang,Liping Guo,Hao Chen,Bien Tan,Shangbin Jin J. Mater. Chem. C, 2020,8, 192-200
• 4. Acenaphthenic hopanoids, a novel series of aromatised
  Teresita Carrillo-Hernández,Philippe Schaeffer,Pierre Albrecht Chem. Commun., 2001, 1976-1977
• 5. An amorphous lanthanum–iridium solid solution with an open structure for efficient water splitting?
  Wei Sun,Chenglong Ma,Xinlong Tian,Jianjun Liao,Ji Yang,Chengjun Ge,Weiwei Huang J. Mater. Chem. A, 2020,8, 12518-12525

Introduction to 4-Amino-3-(trifluoromethyl)picolinonitrile (CAS No. 1805601-57-3) and Its Emerging Applications in Chemical Biology and Medicinal Chemistry

4-Amino-3-(trifluoromethyl)picolinonitrile, identified by the chemical identifier CAS No. 1805601-57-3, is a fluorinated heterocyclic compound that has garnered significant attention in the fields of chemical biology and medicinal chemistry due to its versatile structural framework and potential biological activities. This compound belongs to the picolinonitrile family, which is characterized by a pyridine core substituted with a nitrile group. The presence of a trifluoromethyl group at the 3-position and an amino group at the 4-position introduces unique electronic and steric properties, making it a valuable scaffold for designing novel pharmacological agents.

The trifluoromethyl moiety is particularly noteworthy in medicinal chemistry, as it is frequently incorporated into drug molecules to enhance metabolic stability, improve binding affinity, and modulate pharmacokinetic profiles. In contrast, the amino group provides a site for further functionalization, enabling the construction of more complex derivatives with tailored biological properties. The combination of these structural features has positioned 4-Amino-3-(trifluoromethyl)picolinonitrile as a promising intermediate in the synthesis of bioactive molecules.

Recent advancements in synthetic methodologies have facilitated the efficient preparation of 4-Amino-3-(trifluoromethyl)picolinonitrile, allowing for its exploration in various chemical biology applications. For instance, researchers have leveraged this compound to develop inhibitors targeting enzyme systems involved in inflammatory pathways. The fluorinated pyridine scaffold has been shown to interact selectively with biological targets, offering potential therapeutic benefits in conditions such as cancer and autoimmune diseases.

One of the most compelling aspects of 4-Amino-3-(trifluoromethyl)picolinonitrile is its utility as a building block for small-molecule probes. In chemical biology studies, such probes are essential for elucidating the function of proteins and other biomolecules. The compound’s ability to undergo selective modifications allows researchers to generate derivatives with specific binding properties, which can be used to modulate protein-protein interactions or to visualize cellular processes in real-time.

The incorporation of fluorine atoms into drug candidates has been extensively studied for its impact on pharmacological properties. The electron-withdrawing nature of fluorine can influence the conformation and reactivity of molecules, while also enhancing their bioavailability. In the case of 4-Amino-3-(trifluoromethyl)picolinonitrile, these effects have been exploited to design molecules with improved pharmacokinetic profiles. For example, fluorinated analogs have demonstrated enhanced resistance to metabolic degradation, allowing for prolonged half-lives in vivo.

Moreover, the nitrile group present in 4-Amino-3-(trifluoromethyl)picolinonitrile serves as a versatile handle for further chemical transformations. It can be reduced to an amine or converted into other functional groups, enabling the synthesis of diverse libraries of compounds for high-throughput screening. This flexibility has made it a valuable tool in drug discovery campaigns aimed at identifying novel therapeutic agents.

In conclusion, 4-Amino-3-(trifluoromethyl)picolinonitrile (CAS No. 1805601-57-3) represents a fascinating compound with significant potential in chemical biology and medicinal chemistry. Its unique structural features, including the presence of both an amino and a trifluoromethyl group on a pyridine core substituted with a nitrile moiety, make it an ideal candidate for designing bioactive molecules with tailored pharmacological properties. As research continues to uncover new applications for this compound, it is likely to play an increasingly important role in the development of next-generation therapeutics.

• 332062-08-5(Fmoc-S-3-amino-4,4-diphenyl-butyric acid)
• 1270529-38-8(1,2,3,4,5,6-Hexahydro-[2,3]bipyridinyl-6-ol)
• 2680771-01-9(4-cyclopentyl-3-{(prop-2-en-1-yloxy)carbonylamino}butanoic acid)
• 2098070-20-1(2-(3-(Pyridin-3-yl)-1H-pyrazol-1-yl)acetimidamide)
• 1444113-98-7(N-(3-cyanothiolan-3-yl)-2-[(2,2,2-trifluoroethyl)sulfanyl]pyridine-4-carboxamide)
• 941977-17-9(N'-(3-chloro-2-methylphenyl)-N-2-(dimethylamino)-2-(naphthalen-1-yl)ethylethanediamide)
• 2138166-62-6(2,2-Difluoro-3-[methyl(2-methylbutyl)amino]propanoic acid)
• 89640-58-4(2-Iodo-4-nitrophenylhydrazine)
• 1449132-38-0(3-Fluoro-5-(2-fluoro-5-methylbenzylcarbamoyl)benzeneboronic acid)
• 2034271-14-0(2-(1H-indol-3-yl)-N-{[6-(thiophen-2-yl)-[1,2,4]triazolo[4,3-b]pyridazin-3-yl]methyl}acetamide)